Washington was supposed to lower drug prices in 2019. What happened?
Nearly everyone thought 2019 would be a big year for drug pricing. But neither Congress nor the White House enacted major policies to bring down costs.
Related Articles
A new biotech licensing Chinese drugs with a unique approach gets high-profile backing
Expedition Therapeutics, a new startup hoping to source the best therapies being developed in China and bring them stateside, has secured high-profile backing.
Gene therapies and CRISPR drugs slowed by ‘irrational pessimism,’ say scientists forging new paths
Gene therapy pioneer Jim Wilson and researcher Kiran Musunuru are using contrasting approaches to overcome “irrational pessimism” clouding the field. #STATBreakthrough
Former CDC director Tom Frieden shares warning for RFK Jr. on measles outbreak
Wavering on vaccines and slashing public health spending could allow the Texas outbreak to turn into a disaster, Frieden says at #STATBreakthrough.
Tapping the potential of GLP-1 drugs requires integrated care and overcoming inequities, executives say
At STAT’s Breakthrough Summit East, the CEOs of Ro and Included Health said the the U.S. health care system poses obstacles to maximizing the potential…
Biotech stocks get boost from Fed rate outlook
And other biotech news brought to you by The Readout.
Device maker Zynex Medical under pressure from insurers, SEC filings show
Zynex Medical disclosed that an insurer, a major client, was suspending payments and reviewing prior claims.
Pharmalittle: We’re reading about copycat weight loss drugs, ADHD prescriptions spiking, and more
The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding pharmacies have other plans
How to protect the American egg supply from avian flu
The most effective strategy against bird flu on chicken farms is prevention, writes former FDA Commissioner Scott Gottlieb — and that may include vaccinating chicks.
What happens when police and hospitals confiscate drugs?
Read the Morning Rounds newsletter with all the health news stories you need to read today.
Trump administration policies will create worse health care for intersex people like me
“It seems the Trump administration is arguing that people like me are neither male nor female but simply ‘disordered,’” writes Kimberly Zieselman.